GlaxoSmithKline to publish clinical trials after US lawsuitBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7455.1513-a (Published 24 June 2004) Cite this as: BMJ 2004;328:1513
- Liza Gibson
The world's second largest pharmaceutical company, GlaxoSmithKline, is to publish summaries of the results of all its clinical trials on its website once a product has been launched.
GlaxoSmithKline said it has been considering the move for several months now, but it follows on the heels of a US lawsuit, filed by Eliot Spitzer, New York state's attorney general, earlier this month.
Mr Spitzer alleged the company engaged in “repeated and persistent fraud” for concealing the results of clinical studies for its antidepressant paroxetine; these suggested the drug was ineffective and unsafe in treating depression in children and adolescents (12 June, p 1395).
Mr Spitzer also had an internal …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial